Paper Details

  1. Home
  2. Paper Details

Chemotherapy Treatment and Trials in Low-Grade Gliomas.

Author: DonovanLaura E, LassmanAndrew B

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study reviews the treatment approach for low-grade gliomas, a group of tumors with heterogeneous clinical outcomes. The authors highlight the use of adjuvant chemotherapy with procarbazine, lomustine, and vincristine, as well as temozolomide, to improve survival.
Paper Details　
Original Abstract of the Article :
There is currently no universally accepted standard of care treatment for low-grade gliomas, a molecularly heterogeneous group of tumors with similarly heterogeneous clinical outcomes. Risk stratification by clinical and molecular features is useful to help determine which patients benefit the most ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.nec.2018.08.007

データ提供：米国国立医学図書館（NLM）

Unraveling the Complexities of Low-Grade Gliomas: A Guide to Chemotherapy Treatment and Trials

The field of [neuro-oncology] is constantly seeking new ways to combat [brain tumors]. This research explores the [current treatment approaches] for [low-grade gliomas], a type of [brain tumor] known for its [heterogeneous clinical outcomes]. The authors provide a comprehensive overview of [chemotherapy regimens] and [clinical trials] focused on this challenging disease.

Tailoring Treatment to Individual Patients: A Key for Success

The study emphasizes the importance of [risk stratification] in determining which [low-grade glioma] patients are most likely to benefit from [adjuvant chemotherapy]. This personalized approach helps optimize treatment strategies and improve [patient outcomes].

Navigating the Uncertain Terrain of Low-Grade Gliomas

This research provides valuable insights into the [current landscape] of [low-grade glioma treatment]. While [chemotherapy] can play a significant role in [disease management], it is crucial to understand the [individualized needs] of each patient and to carefully weigh the [potential benefits and risks] of different [treatment options].

Dr.Camel's Conclusion

The desert is a place of constant change and adaptation, and the fight against [low-grade gliomas] is no different. This research provides a map for navigating the complex terrain of this disease, offering insights into the evolving landscape of [treatment options]. As we continue to explore the mysteries of [brain tumors], this research serves as a valuable guide in our pursuit of effective and personalized therapies.

Date :
  1. Date Completed 2019-01-11
  2. Date Revised 2019-01-11
Further Info :

Pubmed ID

30470397

DOI: Digital Object Identifier

10.1016/j.nec.2018.08.007

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.